BRPI0819105A2 - composição para o tratamento e prevenção de edema de pálpebra - Google Patents
composição para o tratamento e prevenção de edema de pálpebraInfo
- Publication number
- BRPI0819105A2 BRPI0819105A2 BRPI0819105A BRPI0819105A BRPI0819105A2 BR PI0819105 A2 BRPI0819105 A2 BR PI0819105A2 BR PI0819105 A BRPI0819105 A BR PI0819105A BR PI0819105 A BRPI0819105 A BR PI0819105A BR PI0819105 A2 BRPI0819105 A2 BR PI0819105A2
- Authority
- BR
- Brazil
- Prior art keywords
- prevention
- treatment
- composition
- eyelid edema
- eyelid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US751107P | 2007-11-08 | 2007-11-08 | |
PCT/US2008/012513 WO2009061431A2 (en) | 2007-11-08 | 2008-11-06 | Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0819105A2 true BRPI0819105A2 (pt) | 2019-09-24 |
Family
ID=40329067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0819105A BRPI0819105A2 (pt) | 2007-11-08 | 2008-11-06 | composição para o tratamento e prevenção de edema de pálpebra |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2219630A2 (pt) |
JP (1) | JP2011503061A (pt) |
CN (1) | CN101977595A (pt) |
AU (1) | AU2008325214A1 (pt) |
BR (1) | BRPI0819105A2 (pt) |
CA (1) | CA2705050A1 (pt) |
MX (1) | MX2010005012A (pt) |
WO (1) | WO2009061431A2 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120225918A1 (en) * | 2011-03-03 | 2012-09-06 | Voom, Llc | Compositions and Methods for Non-Surgical Treatment of Ptosis |
WO2013065720A1 (ja) * | 2011-11-01 | 2013-05-10 | ロート製薬株式会社 | 眼科用水性組成物 |
EA021247B1 (ru) * | 2012-03-26 | 2015-05-29 | Ооо "Фармацевтическая Компания "Славянская Аптека" | Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты) |
EA021234B1 (ru) * | 2012-03-27 | 2015-05-29 | Ооо "Фармацевтическая Компания "Славянская Аптека" | Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты) |
JP6373551B2 (ja) * | 2012-05-30 | 2018-08-15 | 味の素株式会社 | ガロタンニン含有組成物 |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
CN105188691A (zh) * | 2013-05-06 | 2015-12-23 | 阿勒根公司 | 用于治疗组织创伤的α-肾上腺素能激动剂 |
TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
US9820954B2 (en) | 2015-08-19 | 2017-11-21 | Jenivision Inc. | Quantitative peri-orbital application of ophthalmology drugs |
WO2017132410A1 (en) * | 2016-01-26 | 2017-08-03 | Frank Litvack | Compositions and uses of alpha-adrenergic agents |
EP3970803A1 (en) * | 2020-09-22 | 2022-03-23 | Beiersdorf AG | Cosmetic composition of low osmolality |
US20240156786A1 (en) * | 2021-03-03 | 2024-05-16 | Voom, Llc | Compositions and methods for treatment of blepharitis |
CN117771183B (zh) * | 2024-02-27 | 2024-05-03 | 深圳大佛药业股份有限公司 | 一种盐酸羟甲唑啉喷雾剂及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2618428A (en) * | 1947-01-27 | 1952-11-18 | John K M Harrison | Shock resistant container |
US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
IT1248014B (it) * | 1991-06-07 | 1995-01-05 | Inverni Della Beffa Spa | Preparazioni oftalmiche a rilascio protratto |
US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
US7691829B2 (en) * | 1998-03-24 | 2010-04-06 | Petito George D | Composition and method for healing tissues |
US6274626B1 (en) * | 1998-12-22 | 2001-08-14 | Bausch & Lomb Incorporated | Pheniramine-containing compositions and method for treating allergic responses |
JP2001187728A (ja) * | 1999-12-28 | 2001-07-10 | Lion Corp | 眼科用組成物 |
DE10000612A1 (de) * | 2000-01-10 | 2001-07-19 | Min Becker | Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel |
JP2002308775A (ja) * | 2001-04-06 | 2002-10-23 | Rohto Pharmaceut Co Ltd | 外用組成物 |
US7288263B2 (en) * | 2004-09-13 | 2007-10-30 | Evera Laboratories, Llc | Compositions and methods for treatment of skin discoloration |
MX2007006233A (es) * | 2004-11-24 | 2007-11-23 | Medpointe Healthcare Inc | Composiciones que comprenden azelastina y metodos de uso de la misma. |
JP2006232792A (ja) * | 2005-02-21 | 2006-09-07 | Aile De Beaute:Kk | 肌老化改善化粧料 |
EP3150209B1 (en) * | 2006-03-31 | 2019-07-24 | Vistakon Pharmaceuticals, LLC | Ocular allergy treatments |
CA2650592A1 (en) * | 2006-04-26 | 2007-11-08 | Aciex, Inc. | Compositions for the treatment and prevention of eyelid swelling |
-
2008
- 2008-11-06 MX MX2010005012A patent/MX2010005012A/es not_active Application Discontinuation
- 2008-11-06 BR BRPI0819105A patent/BRPI0819105A2/pt not_active IP Right Cessation
- 2008-11-06 WO PCT/US2008/012513 patent/WO2009061431A2/en active Application Filing
- 2008-11-06 AU AU2008325214A patent/AU2008325214A1/en not_active Abandoned
- 2008-11-06 CA CA2705050A patent/CA2705050A1/en not_active Abandoned
- 2008-11-06 JP JP2010533093A patent/JP2011503061A/ja not_active Withdrawn
- 2008-11-06 EP EP08847794A patent/EP2219630A2/en not_active Withdrawn
- 2008-11-06 CN CN2008801191850A patent/CN101977595A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2008325214A1 (en) | 2009-05-14 |
CN101977595A (zh) | 2011-02-16 |
WO2009061431A2 (en) | 2009-05-14 |
JP2011503061A (ja) | 2011-01-27 |
CA2705050A1 (en) | 2009-05-14 |
MX2010005012A (es) | 2010-06-23 |
EP2219630A2 (en) | 2010-08-25 |
WO2009061431A3 (en) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0819105A2 (pt) | composição para o tratamento e prevenção de edema de pálpebra | |
BRPI0819241A2 (pt) | Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas | |
CR11019A (es) | 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas | |
BRPI0916862A2 (pt) | compostos úteis para o tratamento de doenças degenerativas e inflamatórias | |
BRPI0919920A2 (pt) | compostos para tratamento de doenças e desordens oftálmicas | |
BRPI0921237A2 (pt) | métodos e composições para o tratamento de distúrbios associados ao complemento | |
ES2525801T8 (es) | Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes | |
BRPI0716844A2 (pt) | Inidores de quinase úteis para o tratamento de doenças proliferativas | |
BRPI0818799A2 (pt) | Composições para o tratamento da doença de parkinson | |
BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
BRPI0915282A2 (pt) | agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade | |
BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
BRPI1015569A2 (pt) | compostos úteis para o tratamento de doenças degenerativas e inflamatórias. | |
BRPI0917444A2 (pt) | composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
BRPI0816712A2 (pt) | terapia de intervalo para o tratamento de tinnitus | |
BRPI0911612A2 (pt) | composições e métodos para o tratamento da esclerose múltipla. | |
BRPI1007929A2 (pt) | "métodos e composições para o tratamento de neovascularização". | |
BRPI0915439A2 (pt) | composição tópica para o tratamento de ceratose actínica | |
BRPI0917440A2 (pt) | composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho | |
BRPI0923567A2 (pt) | agentes antibactericidas novos para o tratamento de infecções gram positivas | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
BRPI0914454A2 (pt) | "composição para o tratamento do tecido epitelial" | |
BRPI0912890A2 (pt) | composição farmacêutica para o tratamento de ejaculação precoce |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |